# Entrada Therapeutics news releases

- **Website:** https://www.entradatx.com
- **Location:** Boston, United States
- **Releases:** 1
- **First release:** November 18, 2026
- **Most recent:** November 18, 2026
- **Categories:** Nasdaq:TRDA
- **Web page:** https://www.helpareporter.com/news-releases/entrada-therapeutics
- **RSS:** https://www.helpareporter.com/news-releases/entrada-therapeutics/rss.xml

## Releases

### [Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 3 at the Increased Dose of 15 mg/kg in Entrada Therapeutics’ ELEVATE-45-201 Study](https://www.helpareporter.com/news-releases/independent-safety-data-monitoring-committee-recommends-initiation-of)

November 18, 2026 · Nasdaq:TRDA

-- ELEVATE-45-201 Cohort 2 (10 mg/kg) enrollment complete with data expected in H1 2027 -- BOSTON, Nov. 18, 2026 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc.
